Journal article
Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
- Abstract:
-
Background: Studies show that mepolizumab can reduce the frequency of clinically significant exacerbations in patients with severe eosinophilic asthma, compared with placebo. However, important events such as hospitalizations and emergency room visits are rare and difficult to characterize in single studies. Objective: We sought to compare hospitalization or hospitalization and/or emergency room visit rates in patients with severe eosinophilic asthma treat... Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Journal of Allergy and Clinical Immunology Journal website
- Volume:
- 139
- Issue:
- 4
- Pages:
- 1167–1175.e2
- Publication date:
- 2016-01-01
- Acceptance date:
- 2016-10-07
- DOI:
- EISSN:
-
2213-2201
- ISSN:
-
0091-6749
Item Description
- Keywords:
- Pubs id:
-
pubs:648635
- UUID:
-
uuid:c9df29a3-7a71-44f6-bfec-b568b1f0514c
- Local pid:
- pubs:648635
- Source identifiers:
-
648635
- Deposit date:
- 2016-10-11
Terms of use
- Copyright holder:
- GlaxoSmithKline
- Copyright date:
- 2016
- Notes:
-
Copyright © 2016 GlaxoSmithKline. Published by Elsevier Inc. on behalf of the American Academy
of Allergy, Asthma & Immunology. This is an open access article under the CC BY-NCND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record